160 related articles for article (PubMed ID: 2635886)
1. Neopterin as a predictive marker for disease progression in human immunodeficiency virus type 1 infection.
Fuchs D; Spira TJ; Hausen A; Reibnegger G; Werner ER; Felmayer GW; Wachter H
Clin Chem; 1989 Aug; 35(8):1746-9. PubMed ID: 2635886
[TBL] [Abstract][Full Text] [Related]
2. Urinary neopterin concentrations and T-cell subset data in HIV-1 infection.
Reibnegger G; Fuchs D; Goedert JJ; Hausen A; Krämer A; Werner ER; Werner-Felmayer G; Dierich MP; Wachter H
Klin Wochenschr; 1990 Jan; 68(1):43-8. PubMed ID: 1968523
[TBL] [Abstract][Full Text] [Related]
3. Neopterin as discriminating and prognostic parameter in healthy homosexuals, ARC and AIDS patients.
Hutterer J
Wien Klin Wochenschr; 1988 Apr; 100(7):218-9. PubMed ID: 3376481
[No Abstract] [Full Text] [Related]
4. Urinary neopterin concentrations vs total neopterins for clinical utility.
Fuchs D; Milstien S; Krämer A; Reibnegger G; Werner ER; Goedert JJ; Kaufman S; Wachter H
Clin Chem; 1989 Dec; 35(12):2305-7. PubMed ID: 2591046
[TBL] [Abstract][Full Text] [Related]
5. Is T-cell activation an unfavourable sign in i.v.-drug addicts infected with HIV?
Fuchs DN; Hausen A; Hengster P; Reibnegger GJ; Unterweger B; Werner ER; Hinterhuber H; Dierich MP; Wachter H
Cancer Detect Prev; 1988; 12(1-6):277-82. PubMed ID: 3263196
[TBL] [Abstract][Full Text] [Related]
6. Neopterin and beta 2-microglobulin as prognostic indices in human immunodeficiency virus type 1 infection.
Fuchs D; Krämer A; Reibnegger G; Werner ER; Dierich MP; Goedert JJ; Wachter H
Infection; 1991; 19 Suppl 2():S98-102. PubMed ID: 1673120
[TBL] [Abstract][Full Text] [Related]
7. The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1.
Fahey JL; Taylor JM; Detels R; Hofmann B; Melmed R; Nishanian P; Giorgi JV
N Engl J Med; 1990 Jan; 322(3):166-72. PubMed ID: 1967191
[TBL] [Abstract][Full Text] [Related]
8. Neopterin: a predictive marker of acquired immune deficiency syndrome in human immunodeficiency virus infection.
Krämer A; Wiktor SZ; Fuchs D; Milstien S; Gail MH; Yellin FJ; Biggar RJ; Wachter H; Kaufman S; Blattner WA
J Acquir Immune Defic Syndr (1988); 1989; 2(3):291-6. PubMed ID: 2566673
[TBL] [Abstract][Full Text] [Related]
9. Neopterin as discriminating and prognostic parameter in healthy homosexuals, ARC and AIDS patients.
Hutterer J; Fuchs D; Eder G; Hausen A; Knapp W; Köller U; Reibnegger G; Werner ER; Wachter H; Stingl G
Wien Klin Wochenschr; 1987 Aug; 99(15):531-5. PubMed ID: 2958970
[TBL] [Abstract][Full Text] [Related]
10. Neopterin estimation compared with the ratio of T-cell subpopulations in persons infected with human immunodeficiency virus-1.
Fuchs D; Banekovich M; Hausen A; Hutterer J; Reibnegger G; Werner ER; Gschnait FD; Dierich MP; Wachter H
Clin Chem; 1988 Dec; 34(12):2415-7. PubMed ID: 3264225
[TBL] [Abstract][Full Text] [Related]
11. Immunologic markers of progression to acquired immunodeficiency syndrome are time-dependent and illness-specific.
Krämer A; Biggar RJ; Hampl H; Friedman RM; Fuchs D; Wachter H; Goedert JJ
Am J Epidemiol; 1992 Jul; 136(1):71-80. PubMed ID: 1384311
[TBL] [Abstract][Full Text] [Related]
12. [Neopterin--a prognostic marker in HIV infection].
Breustedt W; Rabe H; Volk D; Porstmann P
Dermatol Monatsschr; 1989; 175(4):226-31. PubMed ID: 2499491
[TBL] [Abstract][Full Text] [Related]
13. Serum neopterin changes in HIV-infected subjects: indicator of significant pathology, CD4 T cell changes, and the development of AIDS.
Melmed RN; Taylor JM; Detels R; Bozorgmehri M; Fahey JL
J Acquir Immune Defic Syndr (1988); 1989; 2(1):70-6. PubMed ID: 2783972
[TBL] [Abstract][Full Text] [Related]
14. Clinical and laboratory predictors of survival in Gambian patients with symptomatic HIV-1 or HIV-2 infection.
Whittle H; Egboga A; Todd J; Corrah T; Wilkins A; Demba E; Morgan G; Rolfe M; Berry N; Tedder R
AIDS; 1992 Jul; 6(7):685-9. PubMed ID: 1354448
[TBL] [Abstract][Full Text] [Related]
15. Markers for disease progression in intravenous drug users infected with HIV-1.
Zangerle R; Fuchs D; Reibnegger G; Fritsch P; Wachter H
AIDS; 1991 Aug; 5(8):985-91. PubMed ID: 1685652
[TBL] [Abstract][Full Text] [Related]
16. Individual probability for onset of full-blown disease in patients infected with human immunodeficiency virus type 1.
Reibnegger G; Spira TJ; Fuchs D; Werner-Felmayer G; Dierich MP; Wachter H
Clin Chem; 1991 Mar; 37(3):351-5. PubMed ID: 2004442
[TBL] [Abstract][Full Text] [Related]
17. Neopterin and human immunodeficiency virus infection.
Hofmann B
Eur J Clin Chem Clin Biochem; 1993 Apr; 31(4):191-5. PubMed ID: 8100453
[TBL] [Abstract][Full Text] [Related]
18. Elevated urinary neopterin levels in patients with the acquired immunodeficiency syndrome (AIDS). A preliminary report.
Wachter H; Fuchs D; Hausen A; Huber C; Knosp O; Reibnegger G; Spira TJ
Hoppe Seylers Z Physiol Chem; 1983 Sep; 364(9):1345-6. PubMed ID: 6629341
[TBL] [Abstract][Full Text] [Related]
19. A 90-kDa protein serum marker for the prediction of progression to AIDS in a cohort of HIV-1+ homosexual men.
Briggs NC; Natoli C; Tinari N; D'Egidio M; Goedert JJ; Iacobelli S
AIDS Res Hum Retroviruses; 1993 Sep; 9(9):811-6. PubMed ID: 7504933
[TBL] [Abstract][Full Text] [Related]
20. Immune activation markers to predict AIDS and survival in HIV-1 seropositives.
Fuchs D; Jäger H; Popescu M; Reibnegger G; Werner ER; Dierich MP; Kaboth W; Tilz GP; Wachter H
Immunol Lett; 1990 Oct; 26(1):75-9. PubMed ID: 2125976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
